A reduction of GRP, MGP, and α-smooth muscle actin (ASMA) was observed in tissues cultured in MM conditions, and supplementation with cGRP seemed to restore GRP, MGP and, to a lesser extent, ASMA production in VSMCs (Figure 1d). This evidence concerns the gene GRP and Miyoshi myopathy.